Dr James McNamara
Dr James McNamara
Details
Role
Team Leader / Senior Research Officer
Research area
Stem Cell Medicine
Group
Heart Disease
Dr. James McNamara is a National Heart Foundation Future Leader Fellow and Team Leader of Muscle Signalling at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of inherited cardiomyopathies in which he has made a number of seminal discoveries. He received his PhD in 2017 from the University of Sydney and subsequently undertook postdoctoral training at the University of Cincinnati, supported by the prestigious American Heart Association postdoctoral fellowship. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, has risen to Team Leader, where he continues to study molecular mechanisms of genetic heart diseases, utilising both human pluripotent stem cells as a human model of disease. At 7-years post PhD, his research has attracted over $3 million in competitive funding and has been featured in leading journals such as Nature Cardiovascular Research, Science Translational Medicine, and Cell Metabolism. Recently, he has focused on the molecular function of the atypical kinase, ALPK3, in cardiac health and disease, which forms the basis of this award.
Dr. James McNamara is a National Heart Foundation Future Leader Fellow and Team Leader of Muscle Signalling at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of inherited cardiomyopathies in which he has...
Dr. James McNamara is a National Heart Foundation Future Leader Fellow and Team Leader of Muscle Signalling at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of inherited cardiomyopathies in which he has made a number of seminal discoveries. He received his PhD in 2017 from the University of Sydney and subsequently undertook postdoctoral training at the University of Cincinnati, supported by the prestigious American Heart Association postdoctoral fellowship. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, has risen to Team Leader, where he continues to study molecular mechanisms of genetic heart diseases, utilising both human pluripotent stem cells as a human model of disease. At 7-years post PhD, his research has attracted over $3 million in competitive funding and has been featured in leading journals such as Nature Cardiovascular Research, Science Translational Medicine, and Cell Metabolism. Recently, he has focused on the molecular function of the atypical kinase, ALPK3, in cardiac health and disease, which forms the basis of this award.
Top Publications
- Desai, D, Song, T, Singh, RR, Baby, A, McNamara, J, Green, L, Nabavizadeh, P, Ericksen, M, Bazrafshan, S, Natesan, S, et al. MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids.. bioRxiv 2024 view publication
- McNamara, JW, Song, T, Alam, P, Binek, A, Singh, RR, Nieman, ML, Koch, SE, Ivey, MJ, Lynch, TL, Rubinstein, J, et al. Fast skeletal myosin binding protein-C expression exacerbates dysfunction in heart failure.. bioRxiv 2024 view publication
- Ng, Y-K, Blazev, R, McNamara, JW, Dutt, M, Molendijk, J, Porrello, ER, Elliott, DA, Parker, BL. Affinity Purification-Mass Spectrometry and Single Fiber Physiology/Proteomics Reveals Mechanistic Insights of C18ORF25.. J Proteome Res 23(4) : 1285 -1297 2024 view publication
- dos Remedios, CG, Law, KYC, McNamara, JW, Kraft, T, Peckham, M, van der Velden, J, Linke, WA, Ackerman, M, Sequeira, V, Lal, S, et al. The Molecular Basis of the Frank-Starling Law of the Heart: A Possible Role for PIEZO1?. 25: 99 -124 2024 view publication
- Austin, R, Brown, JS, Casauria, S, Madelli, EO, Mattiske, T, Boughtwood, T, Metke, A, Davis, A, Horton, AE, Winlaw, D, et al. A multitiered analysis platform for genome sequencing: Design and initial findings of the Australian Genomics Cardiovascular Disorders Flagship. Genetics in Medicine Open 2: 101842 2024 view publication
Page 1 of 10